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Abstract: In the search for natural products with properties that may protect against or slow down
chronic and degenerative diseases (e.g., cancer, and cardiovascular and neurodegenerative condi-
tions), phenolic compounds (PC) with benefits for human health have been identified. The biological
effects of PC in vivo depend on their bioavailability, intestinal absorption, metabolism, and interac-
tion with target tissues. The identification of phenolic compounds metabolites (PCM), in biological
samples, after food ingestion rich in PC is a first step to understand the overall effect on human health.
However, their wide range of physicochemical properties, levels of abundance, and lack of reference
standards, renders its identification and quantification a challenging task for existing analytical
platforms. The most frequent approaches to metabolomics analysis combine mass spectrometry and
NMR, parallel technologies that provide an overview of the metabolome and high-power compound
elucidation. In this scenario, the aim of this review is to summarize the pre-analytical separation
processes for plasma and urine samples and the technologies applied in quantitative and qualitative
analysis of PCM. Additionally, a comparison of targeted and non-targeted approaches is presented,
not available in previous reviews, which may be useful for future metabolomics studies of PCM.
Keywords: phenolic compounds; metabolites; sample treatment; NMR; LC/MS; urine; plasma
1. Introduction
For several years, the benefits of phenolic compound (PC) intake have been described,
especially as a protection from cardiovascular diseases [1,2]. The biological effects of PC
in vivo depend on their bioavailability, intestinal absorption, metabolism, and interaction
with target tissues [3]. It is well-known that PC have a low oral bioavailability, and undergo
an extensive biotransformation mediated by phase I reactions (e.g., oxidation, reduction, or
hydrolysis), phase II reactions (e.g., glucuronidation, methylation, sulfation), as well as by
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gut microbiota (e.g., ring fission, hydrolysis, demethylation, reduction, decarboxylation,
dihydroxylation, and isomerization) [4,5]. In fact, the identification, in biological samples,
of the phenolic compounds’ metabolites (PCM) produced after foods rich in PC intake,
is a first step to understand the overall effect on human health [6]. Unfortunately, the
(i) enormous structural variety of PC (i.e., phenolic acids, flavan-3-ols, flavanones, flavones,
flavonoids, lignans, among others), (ii) the lack of commercially available standards, (iii) the
structural variability of PCM, (iv) metabolite degradation due to tedious multi-step sample
preparation workflows, (v) instability of specific compounds, (vi) low analyte concentration,
and (vii) frequent sample contamination [7–10], render their identification a complex task.
In the last decades, pre-analytical separation processes and more powerful separation
systems for their analysis have been applied.
Accurate identification and quantification of analytes greatly depends on the extrac-
tion step [7–11]. Sample preparation, also known as sample pretreatment or clean-up, is a
mandatory step to ensure adequate sensitivity, selectivity, and reproducibility of the analyti-
cal process in metabolomics analyses. The objectives of the pre-analytical separation process
include: (i) minimization or elimination of interferences or undesired endogenous com-
pounds in the extracted samples, (ii) enhanced selectivity for targeted analytes, (iii) sample
preconcentration to improve assay sensitivity, and (iv) sample stabilization by reconstitut-
ing the mixture in an inert solvent. The development of analytical methods for biological
samples has become increasingly challenging due to growing demands for method reliabil-
ity and sensitivity, and speed of analysis and sample throughput. However, the extraction
approach used is often dictated by the characteristics of the target analyte (hydrophilicity,
lipophilicity, and protolytic properties) and the matrix. In liquid chromatography-mass
spectrometry (LC-MS)-based metabolite analyses, sample preparation depends on whether
a targeted or non-targeted strategy is employed [11]. In non-targeted analysis, the main
methods of sample clean-up are the “dilute and shoot” approach, protein precipitation (PP),
and ultrafiltration [11]. In targeted analysis, liquid-liquid extraction (LLE), solid-phase
extraction (SPE), solid-phase microextraction (µSPE), solid-liquid extraction (SLE), and PP
are the most commonly used [11].
In the SPE technique, analytes from the sample solution or extract are concentrated
and purified by sorption on a solid sorbent [12]. SPE efficiency depends on the nature of
the stationary phase, solvent and volume sample, solvent pH, and modifier content [13].
An alternative to conventional SPE, µSPE allows analyte extraction from a small amount
of sample using a low elution volume. Its advantage is that sample extraction and pre-
concentration can be performed in one step, avoiding evaporation and reconstitution,
and therefore reducing the time of analysis [14]. LLE is a technique used to isolate target
compounds that consists of adding an immiscible organic solvent, commonly ethyl acetate,
to the biological sample, which is subjected to vortex-mixing and centrifugation to achieve
the transfer of the analytes to the organic phase [7]. This technique stands out for being
simple to assemble and providing pure extracts, resulting in improved sensitivity in the
chromatographic column [15]. However, if the number of samples is large, LLE is a slow
procedure and requires a high consumption of solvents [16]. Finally, PP involves treating
the samples with a protein precipitant (e.g., water-miscible organic solvents such as ace-
tonitrile (ACN), acetone, ethanol, and methanol), its efficiency depending on the volume of
organic solvent added and the presence of acid [7].
The analytical techniques commonly used for compound identification can measure a
wide range of molecule classes, but each has its limitations regarding detection, sensitivity,
dynamic range, and quantification. In metabolomics, the analytical tools of choice for
small-molecule analysis are mass spectrometry (MS) and nuclear magnetic resonance
(NMR) [17]. Chromatographic techniques for the separation of target compounds, typically
coupled with MS, are liquid chromatography (LC), gas chromatography (GC), or capillary
electrophoresis (CE) [7,17,18].
MS is a highly sensitive method that can detect, quantitate, and structurally eluci-
date several hundred metabolites in a single measurement [17,18]. The sensitivity and
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accuracy of detection by MS depend on the experimental conditions and instrumental
settings, especially the methods of metabolite extraction, separation, and ionization (and
possibly ion suppression) [17]. The most commonly applied ionization techniques, which
are key for compound detection and quantification [17], are electrospray ionization (ESI),
atmospheric pressure chemical ionization (APCI), and matrix-assisted laser desorption
ionization (MALDI) [11,18,19]. The ionization charges neutral molecules so they can be ma-
nipulated by electrical and/or magnetic and/or radio frequency energies according to their
m/z ratio [19]. The most conventional method of ion-fragmentation is collision-induced
dissociation (CID), although surface-induced dissociation (SID) and infrared multiphoton
dissociation (IRMPD) have also been employed [18]. Target compound detection with a
high degree of resolution and sensitivity generally cannot be achieved using a single MS
detection mode, as higher sensitivity leads to lower resolution, and vice versa [17]. Single-
configuration mass analyzers include quadrupole (Q), linear ion trap (LIT), quadrupole ion
trap (QIT), time of flight (TOF), Fourier transform ion cyclotron resonance (FTICR), and Or-
bitrap. Hybrid configuration can further aid metabolite identification by providing highly
resolved and accurate MS/MS spectra [20]. Tandem (MS/MS) mass analyzers for quanti-
tative and qualitative metabolomics studies include triple-quadrupole ion trap (QTrap),
triple quadrupole (QqQ), quadrupole-time-of-flight (Q-TOF), and linear-quadrupole ion
trap-Orbitrap (LTQ-Orbitrap) [17,18,20].
The aim of this review is to highlight recent advances in PCM identification and quantifi-
cation in plasma and urine from humans and animals after the consumption of dietary PC.
Sample preparation methods that enhance analytical sensitivity, identification, confidence, or
the range of PCM that can be identified in these biological samples are described. Finally, the
limitations and advantages of analytical methods in metabolomics studies are outlined.
2. Biological Sample Preparation Methods
There has been considerable progress in the development of sample preparation
methods that allow the detection of PC and PCM with differentiated physicochemical
properties. In LC-MS-based metabolite analyses, the main sample preparation methods
used in non-targeted strategies are “dilute and shoot”, PP, and ultrafiltration, whereas LLE,
SPE, µSPE, SLE, and PP are the most common techniques in targeted analysis [11]. Table 1,
drawing on work of the last two decades, includes the dietary source of each analyzed PC,
the precursor compounds, the PCM type, and the biological sample analyzed. Additionally,
detailed information about PCM of secoiridoids, phenolic alcohols, flavonoids, phenolic
acids, enterolignans, stilbenes, ellagitannins, and others is presented in the Supporting
Information (Supporting Information (Tables S1–S6, respectively). Figure 1 shows the
general clean-up steps for human or animal plasma and urine.
Table 1. Food source of phenolic compounds and the predominant phenolic compound metabolites identified in plasma
and urine samples.
Food or Supplement Compounds Metabolites Sample Ref
VOO/EVOO






















Hydroxytyrosol and derivatives PII/MM [30,31]
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Table 1. Cont.





















Flavonoids and phenolic acids
Plasma/urine
[41]
Yerba mate Flavonols and phenolic acids [42]
Orange juice




















Bilberry Anthocyanins PII Plasma/urine [51]
Black raspberry Anthocyanins PII Urine [52]
Red raspberry Flavan-3-ols and phenolic acids PII/MM Plasma/urine [53]





Anthocyanins and phenolic acids PII/MM [56]
Cranberry juice




Cranberry extract Procyanidins PII/MM Plasma [59]
Cranberry-syrup Flavonoids and phenolic acids PI/PII Urine [60]
Grape pomace drink Flavan-3-ols and phenolic acids PII/MM Plasma/urine [61]
Concord grape juice
Flavonoids and hydroxycinnamic acids PII Plasma/urine [62]
Phenolic acids MM Urine [63]
Grape extract Flavonoids, phenolic acids, and stilbenes PII/MM Urine [64]
PRJD Flavonoids and phenolic acids PII/MM Plasma/urine [65]
PRBF Flavonoids and phenolic acids PII Urine [66]
Apple




AAPO Quercetin PII Plasma [69]
Cocoa
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Tomato sauce with oil Flavanones and hydroxycinnamic acids [3]
Tomato/tomato sauce Flavonoids and phenolic acids PII/MM [81]
Almonds Flavonoids PII/MM Plasma/urine [82]
Beans Flavonoids and phenolic acids PII/MM Plasma/urine [83]


























(-)-Epicatechin and procyanidins PII/MM Plasma/urine [96]
Luteolin PII Plasma [97]
Pill Trans-resveratrol PII/MM Plasma [98]
PI: Phase I metabolites; PII: Phase II metabolites; MM: microbial metabolites; VOO: Virgin olive oil; EVOO: Extra virgin olive oil. PRJD:
Polyphenol-rich juice drink, PRBF: Puree of (poly)phenol-rich berry fruits; AAPO: Applesauce with apple peel and onion.
2.1. Plasma
Plasma is an aqueous solution that contains a great variety of substances, including
proteins, glucose, mineral ions, hormones, carbon dioxide, and blood cells [8], some of
which may interfere with detection of the target analyte. As PCM may have a higher
binding affinity to plasma proteins than the parent compounds [99], proteins and other
cellular components such as phospholipids need to be removed prior to analysis to reduce
potential matrix effects and ion suppression phenomena [100]. An appropriate sample
treatment is therefore a crucial step that influences the reliability and accuracy of the
analysis [16].
2.1.1. Solid-Phase Extraction
PC and PCM extraction from plasma samples is typically performed by C18-bonded
SPE, as it produces results with greater repeatability than techniques such as PP [101].
Other advantages over methods such as LLE include higher recoveries, shorter analysis
time, and lower solvent requirements [12].
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Figure 1. Graphical representation of plasma and urine clean-up and the bioanalysis for the identifi-
cation and quantification of phenolic metabolites.
A range of solvents have been used to extract anthocyanins and their metabolites from
plasma by SPE. PCM elution is frequently carried out with methanol, which efficiently
precipitates proteins and deactivates enzymes, and can be combined with water to improve
the extraction of polar phenolic acids. Some studies have used methanol acidified with
different percentages of formic acid to elute anthocyanins and their metabolites in C18
cartridges [55]. The isolation of anthocyanins and their glucuronide metabolites was also
achieved using hydrophilic-lipophilic-balance (HLB) cartridges and eluting the analytes
with acetone/formic acid (9:1), obtaining a recovery rate of 71% for cyanidine-3-glucose [51].
Anthocyanin and phenolic acid metabolites were also eluted with acetone/formic acid
(9:1) [56]. Acetone has an advantage over methanol in that its lower boiling point allows a
faster evaporation.
The extraction of different classes of flavonoids and their metabolites was performed
using methanol as the elution solvent in mixed-mode cation-exchange (MCX) plates [82].
The samples were previously hydrolyzed or nonhydrolyzed to analyze the metabolites
in both their free and conjugated forms. With this procedure, phase-II metabolites of
flavonoids and their microbial derivatives were identified and quantified, with recovery
values ranging from 87% to 109%. Epicatechin and its metabolites were extracted with dif-
ferent solvents using Strata X cartridges. Actis-Goretta et al., employed methanol/pyridine
(1:1 v/v) to elute the metabolites, mainly glucuronides, sulfates, and O-methyl sulfates,
achieving recoveries from 96% to 104% [77]. These results constitute an improvement on
previous studies that used HLB cartridges with methanol containing formic acid (0.1%) [76]
or N,N-dimethyl formamide/methanol (7:3).
The first validated methodology for the quantification of oleuropein and its metabolites
in plasma was based on sample pretreatment with SPE, using HLB cartridges and acetone as
the eluent. This approach allowed the simultaneous determination of metabolites previously
undetected by other techniques such as LLE, namely 2-(3,4-dihydroxyphenyl)acetic acid,
homovanillyl alcohol, homovanillic acid, and elenolic acid [21].
In a study on procyanidin metabolites, rat plasma samples after ingestion of procyanidin-
enriched cocoa cream were pretreated in offline SPE HLB cartridges. The retained com-
pounds were eluted with acetone/water/acetic acid (70:29.5:0.5, v/v/v), which produced
better results than methanol/acetone, with the recoveries being over 84%. The iso-
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lated procyanidin metabolites were mainly phase-II-conjugated catechin-glucuronide and
epicatechin-glucuronide [73].
A method based on high-throughput µSPE using HLB µElution plates was developed
by Feliciano et al. for the identification and quantification of different classes of PCM,
including flavonols, benzoic acids, catechols, and cinnamic acids. Recovery rates of 89%
were obtained when the µ-elution was performed with methanol followed by 70% aqueous
acidified acetone [57].
Suárez et al. obtained the highest recovery of hydroxytyrosol using 50% aqueous
ACN, although this method was less efficient for other PCM, whose recoveries were better
with methanol [14]. The µSPE method has been used for the analysis of hydroxytyrosol
and derivatives in plasma samples [26,31]. In another study evaluating methanol as the
elution solvent, recoveries of over 75% were achieved for all the studied PCM, including
catechol sulfate and valerolactone glucuronide [67].
2.1.2. Liquid-Liquid Extraction
In a study on the pharmacokinetic processes of flavan-3-ols [96], LLE was carried out
to extract phase-II-conjugated compounds and gut microbiota metabolites. The spiked
samples, previously acidified with formic acid, were extracted 3 times with ethyl acetate,
yielding recoveries of 70–100%. However, the values for cinnamic acids varied considerably,
suggesting that the solvent was not suitable for its extraction. Ethyl acetate was also
employed in an LLE of gallic acid metabolites in human plasma, with the recoveries
ranging from 67% to 96% [89], and in the clean-up of rat plasma containing caffeic, ferulic,
and isoferulic acid metabolites [91].
2.1.3. Protein Precipitation
Plasma contains a large amount of proteins that should be removed to avoid inter-
ference in the final analysis [99]. Samples are treated with a protein precipitant, com-
monly water-miscible organic solvents such as ACN, acetone, perchloric acid, ethanol,
and methanol. Both composition and volume of the organic precipitant can affect PP
efficiency, which may be improved by adding an acid (e.g., formic, acetic, trichloroacetic,
and phosphoric) to the sample or PP solution to alter the pH of the sample matrix [7].
Although PP is a simple and fast method, it does not provide a completely clean extract.
Protein removal can also be achieved by the addition of acids such as trichloroacetic or
perchloric acids, which have a denaturation and aggregation effect.
Other components of plasma samples that could interfere with the analysis are phos-
pholipid species, which may impair both the ionization process and chromatographic
separation, thereby reducing extraction efficiency, recovery, and reproducibility, and in-
creasing inter-sample variability. The removal of phospholipids (highly ionic) has been
successfully accomplished with recently developed commercial plates [102].
ACN and formic acid (2%) were used to extract red raspberry anthocyanins and
ellagitannins and their phase-II metabolites from human plasma [53]. The same solvents
were employed in an analysis of phase-II metabolites of flavonoids and phenolic acids
and phase-II and microbial metabolites of flavanone in plasma after the consumption of
orange juice.
Ethanol has been utilized in different studies as a protein precipitant, including in an
evaluation of chlorogenic and phenolic acids and their metabolites in human plasma after
coffee consumption, and the recoveries ranged from 98.1% to 108.6% for all the glucuronide,
sulfate, and lactone metabolites of the studied phenolic acids [36]. A similar procedure was
performed to isolate chlorogenic acids and their metabolites, although the plasma samples
were resuspended in sodium acetate buffer and acidified with hydrochloric acid in aqueous
methanol (40%, v/v), achieving an 88% recovery of chlorogenic acid [35]. In another study,
coffee phenolic metabolites thought to be formed by the gut microbiota were identified
after ethanol-induced PP and sample acidification with perchloric acid [37].
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2.2. Urine
Urine contains high concentrations of urea, inorganic salts (chloride, sodium, and
potassium), creatinine, ammonia, organic acids, various water-soluble toxins, and pig-
mented products of hemoglobin breakdown [103]. Although urine is one of the easiest
biological fluids to collect, its high salt concentration can easily interfere with ESI. Thus,
the electrolytes need to be removed prior to the analysis [27], which is usually partially
achieved by SPE, LLE, and sample dilution. Nevertheless, direct analysis of urine (unpro-
cessed urine) has also been carried out.
2.2.1. Solid-Phase Extraction
One of the most widely used techniques for the preconcentration and clean-up of
urine samples is SPE, in which the nature and volume of the elution solvent are important
factors [73]. This technique has been used for metabolite extraction of PC from the main
dietary sources such as tomato [3], tomato sauce [80], extra virgin olive oil [22,25,30], red
wine [49,104], black raspberry [52], chokeberry [54], cocoa [70,71,79], chocolate [77], and
anthocyanins [105]. An SPE method for the quantification of 350 dietary markers, including
(poly)phenolic aglycones, phase-II metabolites, microbial-transformed compounds, and
other dietary components, was also developed [106].
Methanol and water are by far the most extensively used solvents for PCM extrac-
tion [3,22,25,30,52,54,70,71,77,79,80,105]. Methanol and ethyl acetate have also been used
to isolate PCM, specificity, and resveratrol metabolites [49,104]. On the other hand, the
methanol and ammonium formate have been less used [106].
Another strategy to optimize the PCM extractions is the use of different additives
during its washing and elution. In this sense, formic acid [3,30,52,70,71,77,80,105,106],
acetic acid [22,49,104], and trifluoroacetic acid [54] are the most common additives used.
In other studies, both the methanol and water were employed without the addition of any
additive [25,79].
In some cases, urine dilution, before SPE extraction, may be necessary to reduce the
ionic strength prior to ion-exchange SPE due to a high concentration of salts [7]. Water [3],
water with trifluoroacetic acid [22,54], water with phosphoric acid [25,49,104], water with
formic acid [106], and methanol [30] have been extensively used prior to SPE extraction. In
other studies, the urine dilution was not employed [52,70,71,79]. Finally, in another study,
it was demonstrated that a complete evaporation of the eluent (to dryness) significantly
reduced the recovery of certain compounds [105].
µSPE constitutes an excellent option for PCM analysis as it requires small sam-
ple volumes. Feliciano and coworkers developed a rapid and high-throughput µSPE
method for the analysis of the most representative polyphenol classes (flavan-3-ols, ben-
zoic acids, phenylacetic acids, propionic acids), achieving recoveries of up to 88% when
using methanol followed by 70% aqueous-acidified acetone as the elution solvent [57]. In
2013, Serra demonstrated that a clean-up step was not necessary in the µSPE method for
hydroxytyrosol metabolites, which was attributed to their polarity. Thus, these compounds
were eluted with water without affecting the matrix effect (lower than 18%) [24]. µSPE was
used with the aim to detect phenol metabolites in urine samples to identify the most appro-
priate compliance olive oil markers and eventually relate them to the expected biological
effects [31].
2.2.2. Liquid-Liquid Extraction
This technique has been used for the extraction of PCM from the main dietary sources,
such as extra virgin olive oil [27,107], orange juice [44], tea [38], yerba mate [42], puree of
five (poly)phenol-rich berry fruits [66], cocoa products [72], and specific compounds, such
as resveratrol [90] and daidzein and genistein [78].
ACN has been extensively employed for LLE of PCM [44,46,48,66]. In other studies,
ethyl acetate [27,107] and dichloromethane have also been employed for the extraction
of PCM [38]. Although LLE can be carried out with a single solvent, the use of solvent
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mixtures can improve extraction [7]. An ACN/methanol mixture (8:2, v/v) was used to
extract major phase-II metabolites of resveratrol [90], adding an acetate buffer to increase
the density of the aqueous layer.
LLE constitutes an excellent option for PCM analysis as it requires small urine volumes
(<500 µL). Another advantage of LLE is that sample extraction can be performed in one
step, avoiding evaporation and reconstitution, and therefore reducing the time of analysis.
In this sense, after centrifugation (and/or filtration), the samples can be directly injected
in MS.
2.2.3. Urine Dilution
The preparation of samples using the “dilute and shoot” approach reduces the time
required to obtain results [11]. Different volumes of water (1:1, 1:3, 1:4, 1:5, or 1:10 v/v,
urine:water), with or without formic acid (0.1%) or acetic acid [23], have been used to
analyze a wide variety of PCM. After dilution, the samples are usually mixed, centrifuged,
and filtered prior to the bioanalysis. In 2019, González-Domínguez and colleagues demon-
strated that a 10-fold dilution factor was optimum for a minimal matrix effect provoked by
the high salt content of urine [106]. The same authors found that this strategy yielded LOQs
above 10 µg L−1 for almost all compounds monitored, which can hinder the detection
of food-derived metabolites in real urine samples. Hydrochloric acid (0.1 M) has been
employed in urine treatment for the analysis of microbial metabolites, glucuronides, and
sulfate derivatives [64]. The same acid was used to retard bacterial growth and ensure
metabolite stability in human urine after the consumption of black tea [64].
2.2.4. Unprocessed Urine
The direct injection of urine samples is known to be difficult due to problems such
as column clogging and MS signal alterations caused by endogenous compounds. Nev-
ertheless, unprocessed urine samples have been analyzed, in nontargeted approaches,
to determine the profile of excretable PC. Unprocessed urine containing metabolites of
flavonoids and hydroxycinnamic acids after the acute consumption of grape juice [62],
hydroxycinnamate derivatives after the acute consumption of coffee [34], and PCM after
polyphenol-rich juice drink [65] and moderate wine [48] consumption have been analyzed.
The urine samples were centrifuged, to eliminate cells and noncellular suspended particles,
before being directly analyzed by UHPLC−TOF-MS [48] or HPLC-PDA-LIT [34,62,65].
3. Identification and Quantitation of Metabolites
3.1. Nontargeted Approaches
Nontargeted approaches to PC and PCM characterization are becoming more feasible
with the high analytical power provided by high-resolution mass spectrometry (HRMS)
instruments (MS and MS/MS mode) [108,109]. In Table 2, the main chromatographic and
MS conditions employed in nontargeted studies of PCM in urine and plasma samples
are summarized.
Q-TOF-MS is a hybrid analytical technique widely used in metabolomics. This com-
bination of analyzers takes advantage of the higher MS/MS efficiency demonstrated by
QqQ instruments and the speed and sensitivity of a TOF analyzer [69,110,111]. A Q-TOF-
based metabolomics approach is a suitable strategy to understand the effect of nutritional
interventions, reveal metabolomic changes, and obtain data on bioaccessibility and bioavail-
ability [111]. A comprehensive list of the main conditions used to analyze dietary PCM in
urine and plasma is provided in Table 2.
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Table 2. Methods for untargeted analysis of PCM in urine and plasma samples.
Phenolic Compounds Sample; Sample Clean-Up;Internal Standard Chromatographic Conditions MS Conditions
Phase-I and Phase-II Metabolites
Quercetin [86] Urine and plasma; PP Acquity BEH C18 (2.1 × 50 mm, 1.7 µm);A: Water (0.1% FA). B: ACN. QTOF; ESI-[M−H]
−
Secoiridoids [29] Urine and plasma; UU andPP
Hypersil gold C18 (2.1 × 100 mm,




Urine and plasma; SPE
Acquity BEH C18 (2.1 × 100 mm, 1.7 µm);






Acquity BEH C18 (2.1 × 100 mm, 1.7 µm);
A: Water (0.1% FA). B: ACN.
LTQ-Orbitrap;
ESI-[M−H]−/[M+H]+






Zorbax Eclipse C18 (4.6 × 150 mm,
1.8 µm);




Zorbax Eclipse C18 (4.6 × 150 mm,




Procyanidins [59] Plasma; PP; mixturesolution **
ACE Excel 2 C18-PFP (2.1 × 100 mm,
2 µm); A: Water (0.1% FA). B: ACN. Q-Exactive;
HESI-[M−H]−
Resveratrol [98] Plasma; PP; mixturesolution *
Nucleodur C18 Isis (2 × 150 mm,1.8 µm);
A: Water, B: MeOH, both with 0.1% FA.
Quercetin [69] Plasma; PP; Quercetin4′-O-glucoside
Poroshell C18 (2.1 × 100 mm, 2.7 mm); A:
Water, B: ACN, both with 0.1% FA.
QTOF;
ESI-[M−H]−/ [M+H]+





Urine; LLE; Rutin and
taxifolin
Synergi Hydro RP18 C18 (2 × 150 mm,
4 µm); A: Water, B: ACN (0.1% FA). LTQ-Orbitrap;
ESI-[M−H]−
Isoflavones [84] Urine and plasma; SPE Kinetex C18 (2.1 × 100 mm, 1.7 µm); A:Buffer (0.1% FA). B: ACN.
Phase-II and Microbial Metabolites





Urine and plasma; µSPE;
Taxifolin
Zorbax Eclipse Plus RRHD (2.1 × 50 mm,
1.8 µm);
A: Water, B: ACN, both with 0.1% FA.
Phenolic acids
and flavonols [42,72] Urine and plasma; LLE, PP
and UD
Ascentis Express C18 (3 × 150 mm,
2.7 µm);
A: Water, B: ACN, both with 0.1% FA.Phenolic acids [32]
Flavan-3-ol [50] Urine and plasma; PP
Kinetex Phenyl-Hexyl (4.6 × 150 mm,






Plasma; PP; Baicalin and
genistein
7-β-D-O-glucuronide
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Table 2. Cont.
Phenolic Compounds Sample; Sample Clean-Up;Internal Standard Chromatographic Conditions MS Conditions




flavonoids [48] Urine; UU
Zorbax Eclipse Plus C8 (2.1 mm ×
100 mm, 1.8 µm);




acids, and flavonols [64] Urine; UD
Luna C18 (2.0 × 50 mm, 5 µm);
A: Water, B: ACN, both with 0.1% FA
LTQ-Orbitrap;
ESI-[M−H]−
Flavan-3-ol [79] Urine; SPE: Hesperetin Poroshell C18 (0.5 × 250 mm, 2.7 µm);A: Water, B: ACN, both with 0.1% FA
QTOF;
ESI-[M−H]−/[M+H]+
AA: acetic acid; ACN: acetonitrile; FA: formic acid; UD: urine dilution; UU: unprocessed urine; SPE: solid-phase extraction; PP: protein pre-
cipitation; µSPE: micro-elution solid-phase extraction; * L-tryptophan-D3, L-leucine-D10, creatine-D3, and caffeine-D3; ** trans-resvératrol-
13C6, trans-resveratrol-3-O-sulfate-D4, trans-resveratrol-3-O-β-D-glucuronide-D4, and trans-resveratrol-4′-O-β-D-glucuronide-D4.
Although Q-TOF-MS has been applied to detect phase-I metabolites in vivo [60,86],
conjugated metabolites have received more attention. Thus, glucuronide and sulfate forms
of quercetin were the main metabolites identified in human plasma post-consumption of
applesauce enriched with apple peel and onion [69]. In another study, phase-II metabolites
were identified in rat plasma and urine after a single oral administration of quercetin [86].
Human urinary metabolites, mainly sulfated forms of caffeic and ferulic/isoferulic acids,
were detected after consumption of yerba mate [42]. Other studies have focused on the
identification of PCM after ingestion of cranberry syrup [60], cranberry juice [57], orange
juice [44], and chocolate [79].
The key role played by phenolic microbial metabolites in the health effects of dietary
PC has prompted experiments on Q-TOF-based metabolomic fingerprints in biological
fluids. Gut microbial metabolites were analyzed in plasma and urine samples following
the consumption of cranberry juice [57], cocoa products [72], beans [83], and tomato
products [81]. Hydroxycinnamate metabolites derived from microbiota were detected
in both plasma and urine after coffee intake [32], and microbial metabolites in urine
were found to be strongly affected by moderate red wine consumption [48]. In summary,
negative ESI (Table 2) is the most frequently used mode in analysis of PCM, regardless of
whether they are phase I, phase II, or microbial metabolites. Regarding chromatographic
separation, the most employed mobile phases are water and ACN with formic acid (0.1%
or 0.01%).
The prediction, screening, and identification of PCM in foods is rarely straightforward.
The Orbitrap mass analyzer, the first high-performance mass analyzer able to trap ions in
electrostatic fields, provides the high-resolution, mass accuracy, and sensitivity required for
metabolomic analyses [112,113]. Two major families of instruments are used to study PCM:
the hybrid linear ion-trap Orbitrap MS (LTQ-Orbitrap) and Q Exactive. Table 2 summarizes
the chromatographic and MS conditions used in the analysis of PCM.
In the most frequently employed operation mode, the Orbitrap mass analyzer acquires
FTMS data and the LTQ provides data-dependent MS/MS scans after trapping. The
advantages are the high trapping capacity and MSn scanning function of the LTQ along
with accurate mass measurements, resulting in greater throughput and identification of
major or trace metabolites. To date, the LTQ-Orbitrap mass analyzer is the most popular
platform used in dietary PC metabolomics research, applied to study the metabolism of
compounds such as (-)-epicatechin [87], oleocanthal [93,94], oleacein [95], daidzein [88],
hesperetin, and hesperidin [92], and to identify PCM in biological samples after the intake
of foods or beverages [41,64,66,81,84]. As can be seen in Table 2, negative ESI is the most
routinely used mode in PCM analysis. Although high mass resolution is necessary to
separate or resolve two peaks with a small mass difference, in most of the studies, the
resolution was set at 30,000 in FTMS mode. A resolution of 60,000 was used in only
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one study and 70,000 in another. Regarding the chromatographic conditions, the most
employed mobile phases are water and ACN or methanol with formic acid (0.1% or 0.01%).
Another newly developed method is Q Exactive hybrid quadrupole-orbitrap mass
spectrometry (Q Exactive MS), which combines high-performance quadrupole precursor
selection with high-resolution and accurate-mass orbitrap detection. In the field of PC
analysis, from 2015 until the present, this hybrid technology has been used in only a few
studies, to identify proanthocyanidin [50], procyanidins [59], resveratrol [106], flavanone,
and secoiridoids [29]. Most (80%) of these studies used heated electrospray ionization
(HESI), which generally gives improved signals compared to the more traditional unheated
ESI (Table 2). Chromatographic separation was carried out as in the LTQ-Orbitrap system,
using water and ACN or methanol with formic acid (0.1% or 0.01%).
3.2. Targeted Approaches
Targeted analyses require the collection of specific metabolite information, typically
through the use of low-resolution mass spectrometry (LRMS) instrumentation. There
are several types of mass analyzers that can generate mass measurements, but the most
frequently used are QqQ or QTrap [114]. Table 3 summarizes the main chromatographic
and MS conditions employed in targeted studies of PCM in urine and plasma samples.
It is well-known that due to the lack of bioanalytical standards for some PCM, various
strategies have been used trying to solve this problem: (i) quantification of PCM using
the calibration curves corresponding to their phenolic precursors or with the most struc-
turally similar compound [42,43], (ii) expressing the concentration as equivalents of parent
compounds [71,94], (iii) expressing the concentration as ratios [29,93,95,115], and (iv) the
synthesis of the target metabolites [39]. In the case of the expression of the concentration as
ratios, the peak abundance ratio (analyte/internal standard) and the concentration ratio
(analyte/internal standard) are used [115]. In other cases, the peak area ratios of each
analyte vs. that of the internal standard (analyte/internal standard) are employed [21,63].
3.2.1. Quadrupole Ion Trap (QIT)
QIT, despite being one of the first technologies employed to analyze dietary PC, has
been applied in only a few studies to date. Its principal limitation is a relatively low limiting
value of the mass/charge ratio. As can be seen in Table 3, the quantification of PCM with
this technology has focused on flavonoids [38,62,65,116] and phenolic acids [62], both in
plasma and urine samples, using ESI and fragmentation by CID. A single mobile phase
was employed in two studies [62,65], whereas others used a combination of two [116] or
three [38]. In all cases, formic or acetic acids (0.05%, 0.1%, or 0.5%) were the major additives
used to improve compound ionization.
3.2.2. Triple Quadrupole (QqQ)
Due to its high sensitivity and selectivity, QqQ mass spectrometry has been primarily
applied in targeted analysis of dietary PCM. Table 3 summarizes the chromatographic and
MS conditions routinely used in the study of PCM.
Phase-I metabolites of oleuropein in plasma samples were analyzed with QqQ tech-
nology, employing a C8 column with water (pH 5, adjusted with acetic acid) and ACN for
chromatographic separation [21]. To quantify phase-I and phase-II metabolites of oleocan-
thal, a C18 column and water:MeOH, both with 0.1% formic acid, was used [93]. In addition,
phase-II metabolites of phenolic acids [14,36], phenolic alcohols [14,25], flavonoids [14,77],
phenyl-γ-valerolactones [39], procyanidins [117], and resveratrol [90] were studied, em-
ploying a C18 column and water:ACN for plasma samples and ammonium acetate:ACN
for urine.
Water and ACN containing formic acid (0.1%, 0.2%, and 0.5%) in combination with C18
columns have been extensively used in the analysis of phase-II metabolites and microbial
metabolites of flavonoids [56,61,66,68,71,80] and phenolic acids [61,66,80] in plasma or
urine samples. The same mobile phases have been used in the analysis of epicatechin and
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procyanidin microbial metabolites [70] in urine samples. In another study, a PFP column
was used to separate polar compounds, including phenolic acid metabolites [53].
3.2.3. Triple-Quadrupole Ion Trap (QTrap)
QTrap is the one of the most widely used instruments for analyzing specific metabo-
lites of interest [108]. Recently, targeted metabolomic profiling of the urinary [106] and
plasma [118] food metabolome has resulted in the simultaneous quantitation of PCM,
including (poly)phenolic aglycones, conjugated metabolites, and colonic microbial metabo-
lites. QTrap technology has been extensively utilized to develop a targeted metabolomic
approach for specific PC groups, being applied to plasma and human urine containing phe-
nolic acid metabolites [119] or specific compounds such as chlorogenic acid [33]. Regarding
flavonoids, phase-I, phase-II, or microbial metabolites were detected in plasma [97] and
urine [46,78,105]. As shown in Table 3, acetic and formic acids are the major additives used
to improve compound ionization. The most common mobile phases for urine are both
ammonium acetate and water (with acid), together with ACN/methanol, and for plasma,
water, and ACN.






Chromatographic Conditions MS Conditions LOQ
Phase I Metabolites
Oleuropein [21] Plasma; SPE;2-hydroxyphenylethanol
RP-C8 (150 × 2.1 mm, 3.5 µm);
A: Water pH 5, adjusted with
AA. B: ACN
QqQ; MRM;





Plasma and urine; PP
and UU; Ethyl gallate
Synergi RP-Max (4.6 × 250 mm,
4 µm); MeOH (0.5% AA or
1% FA).
QIT; FS, CRM, and SIM;
ESI- [M−H]−/ [M+H]+
Flavonoids [116] Plasma and urine;LLE, SPE, and PP
Symmetry C18 (2.1 × 50 mm,
3.5 µm);
A: Water, B: ACN, both with
0.05% FA.
QIT; FS; ESI- [M−H]−/
[M+H]+
Catechins [38] Urine; LLE
Supelcosil LC18 (3.0 × 100 mm,
5 µm);
A: MeOH-water-AA (1:98:1), B:
MeOH- water-AA (50:49:1), C:
MeOH-water (4:1).
QIT; FS; ESI- [M−H]−
Phenolic acids [36] Plasma; PP; mixturesolution *
Acquity BEH C18 (2.1 × 150 mm,
1.7 µm);




Procyanidins [117] Plasma; SPE; Catechol
Acquity HSS T3 (2.1 × 100 mm,
1.8 µm);







Catechol and caffeic acid
Acquity BEH C18 (2.1 × 100 mm,
1.7 µm);









Acquity BEH C18 (2.1 × 100 mm,
1.7 µm);
A: 1 mM ammonium acetate
(pH 5), B: ACN
QqQ; MRM; ESI-
[M−H]− 1.87–20 ng L
−1







Chromatographic Conditions MS Conditions LOQ
Resveratrol [90] Urine; UD; Wogonin
ODS-3 (5 × 150 mm, 2.1 µm);
A: 5 mM ammonium acetate,
B: ACN
QqQ; SRM; ESI-
[M−H]− 4–20 ng L
−1
(–)-Epicatechin [77]
Plasma and urine; SPE;
Umbelliferone sulfate
and glucuronide
HSS C18 (1.8 × 100 mm, 2.1 µm);






[39] Plasma and urine; PP
and UD
Kinetex EVO C18 (2.1 × 100 mm,
2.6 µm);








genistein [78] Urine; LLE; Taxifolin
Phenomenex C18 (3 × 150 mm,
3 µm);
A: ammonium acetate (13 mM,
pH 4 with 0.1% AA), B: MeOH
(0.1% AA).
QTRAP; MRM; ESI-
[M−H]− 3 ng mL
−1
Luteolin [97] Plasma; PP
Capcell pak C18 MGII
(4.6 × 150 mm, 3 µm); A: water
(0.1% TFA), B: ACN.
QTRAP; MRM; ESI-
[M+H]+
Phase I and II Metabolites
Chlorogenic
acid [33]
Urine and plasma; PP;
mixture solution *
Synergi Polar RP C18
(4.6 × 250 mm, 4 µm); A: Water,









Synergi Polar RP C18
(4.6 × 250 mm, 4 µm); MeOH
(0.5% AA or 1% FA).
QIT; FS, SRM, SIM, and
CRM; ESI-[M−H]−/
[M+H]+
Oleocanthal [93] Plasma; SPE
AcQuity BEH C18 (2.1 × 50 mm,
1.7 µm);




Anthocyanins [120] Plasma and urine; SPE;Scopoletin
Kinetex PFP (4.6 × 100 mm,
2.6 µm);






procyanidins [70] Urine; SPE; Ethyl gallate
Luna C18 (2.0 × 50 mm, 5 µm);
A: Water/ACN (94.9:5, v/v), B





Flavanones [46] Urine; LLE
ACE 3 C18-AR (4.6 × 75 mm,
3 µm);
A: Water, B: ACN, both with
0.1% FA.
Phase-II and Microbial Metabolites
Flavonoids and
phenolic acids [66]
Urine; LLE; Rutin and
taxifolin
Atlantis T3 (2.1 × 100 mm,
3 µm);
A: Water/ACN (95:5, v/v), B:















Luna C18 (2.0 × 50 mm, 5 µm);












Plasma and urine; SPE
and UD
Kinetex EVO C18 (2.1 × 100 mm,
2.6 µm);




Flavan-3-ols [68] Urine; UD QqQ; MRM; ESI-M−H]−
Phenolic acids [56] Plasma; SPE; Syringicacid
Pursuit 3 PFP (150 × 2.0 mm);
A: Water, B: ACN, both with
0.1% FA. QqQ; MRM;
ESI-[M−H]−/ M+H]+
Anthocyanins [56] Plasma; SPE;Malvidin-3-O-glucoside
Poroshell 120 C18
(2.1 mm × 150 mm, 2.7 µm); A:









Luna Omega Polar C18
(100 × 2.1 mm, 1.6 µm); A:
10 mM ammonium formate
(0.1% FA), B: ACN.
QTRAP; MRM; ESI-
[M−H]− 10 µg L
−1
Plasma; PP and SPE;
Ferulic acid-1,2,3-13C3,
L-phenylalanine-15N
Luna Omega Polar C18
(100 × 2.1 mm, 1.6 µm); A:
Water, B: ACN, both with
0.5% FA.
QTRAP; MRM;






Kinetex PFP (4.6 × 100 mm,
2.6 µm);




AA: acetic acid; FA: formic acid; TFA: trifluoroacetic acid; SRM: selective reaction monitoring; SIM: selected ion monitoring, CRM:
consecutive reaction monitoring; TIS: turbo ion spray; UD: urine dilution; UU: unprocessed urine; HESI: heated-electrospray ionization
source. * d13C2-caffeic acid, d3-dihydroisoferulic acid, and d3-dihydroisoferulic-3′-O-glucuronide.
3.3. GC-MS
GC is generally recognized to be more reproducible, cheaper, and producing higher
resolution than LC [112,121]. However, in PC analysis, its limitations have tipped the
scales in favor of LC. Since the development of LC, there has been little evolution in GC
methodologies, which in recent publications are clearly surpassed by LC [121]. The main
disadvantage of GC is that the analytes need to be volatile (or transformed into volatile
or semi-volatile compounds) and thermally stable, so their boiling temperature should
be lower than 350–400 ◦C [122]. Secondly, it is necessary to add a derivatization step
prior to the injection to generate phenolic derivatives that can be analyzed by GC. This
procedure is performed with methylating or silylating reagents, most commonly N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA), trimethylchlorosilane (TMCS), N-methyl-
N-(trimethylsilyl) (MSTFA), 1,1,1,3,3,3-hexamethyldisilazane (HMDS), N-methyl-N-(tert-
butyldimethylsilyl)trifluoroacetamide (MTBSTFA), and tetramethylammonium hydroxide
(TMAH) [112].
The combination of GC with MS provides a sensitive technique for the identification
and quantification of PCM [121]. Flavonoids possess physicochemical properties that make
them especially suitable for GC-MS analysis [123]. Isoflavones and flavonoids and their
metabolites were studied in urine samples previously derivatized with MSTFA [124]. An-
other study identified phase I metabolites of isoflavones after performing the derivatization
with pyridine/HMDS/TMCS, 9:3:1 [125].
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In 2018, Ordóñez et al. compared the use of GC-MS and HPLC-MS for the analysis
of microbial-derived phenolic acids in urine. Interestingly, they observed that GC-MS is
not suitable for the analysis of phase-II glucuronide and sulfate metabolites, which are
insufficiently volatile. However, other microbial urinary phenolic metabolites, such as
caffeic acid, ferulic acid, or isoferulic acid, were detected after using MSTFA as a deriva-
tization agent [126]. Most studies employing GC-MS to analyze PCM have focused on
colonic metabolites after the consumption of polyphenol-rich foods. It was used by Draijer
et al. to obtain a fingerprint of phenolic acids in urine, employing BSTFA with 10% TMCS
to derivatize the metabolites [127]. Other studies used pyridine and MSTFA (1:4, v/v) or
BSTFA/TMCS (90:10 v/v) to achieve the separation and identification of phenolic acids and
aromatic acids produced by the gut microbiota [45,63]. The main metabolites of chlorogenic
acid, caffeic, and ferulic acid were analyzed in plasma samples after coffee intake. The
derivatization of the analytes was carried out with MTBSTF and 1% tert-butyldimethylsilyl
chloride, and the products were redissolved in hexane prior to injection [110].
GC-MS/MS was used to characterize the urinary metabolites of olive oil PC in sam-
ples derivatized with MSTFA/1-(trimethylsilyl)imidazole (TMSI) 1000/2 (v/v), resulting
in the identification and quantification of free and conjugated forms of hydroxytyrosol,
tyrosol, and elenolic acid [22]. In another study on olive oil, metabolites of hydroxytyrosol,
homovanillic alcohol, and homovanillic acid were identified and quantified after their
transformation into trymethylsilyl ether derivates [28].
The application of GC to determine PCM is not limited to its coupling with MS.
GC-QqQ/MS was applied by Carry et al. to analyze microbial phenolic acid metabolites
of grape epicatechin and catechin [128]. Furthermore, Kay et al., employed GC with a
flame ionization detector to identify the glycosylating structures of cyanidin, and the
derivatization of sugars was performed with TMSI + pyridine [54].
3.4. NMR
NMR spectroscopy is a potent tool for the qualitative and quantitative analysis of
complex mixtures of small molecules and has been used to analyze PC in food [129–131].
NMR-based metabolomics offers a powerful approach to metabolite fingerprinting and
profiling [132]. As well as being non-destructive, quantitative, and highly reproducible,
this technique requires minimal sample preparation, allows the identification of new
compounds, and is information-rich for the characterization of molecular structures, partic-
ularly in complex mixture analyses [133]. However, a limiting factor is the complexity of
interpreting the NMR spectra of biological samples, due to signal overlap and crowding,
so multivariate statistical analysis is essential [129,130,134]. A study in 2005 profiled the
flavonol metabolites of black tea in urine samples using 1H NMR spectroscopy followed by
pattern recognition techniques, which converted the NMR spectra into a set of spectroscopic
integrals used as descriptors for principal component analysis [40].
An 1H NMR metabolomic approach was also used to profile the metabolomic changes
in plasma arising from the consumption of cranberry procyanidins [59]. Similarly, urinary
metabolome changes in female Sprague–Dawley rats were examined after the administra-
tion of partially purified cranberry or apple procyanidins [135], and recently, an in-depth
analysis of the effects of resveratrol on the urinary and fecal metabolome of female Wis-
tar rats [136] was performed. 2D NMR spectra (heteronuclear single-quantum correlation
(HSQC) or heteronuclear multiple-quantum correlation (HMQC) spectroscopy) were used in
some examples to assist the metabolite identification and confirm the metabolite assignments.
The complexity of the urine matrix, together with the low concentration of the con-
jugates, which have many possible isomeric forms, requires the occasional use of an
SPE sample preparation procedure to both purify and concentrate the PC metabolites
before NMR analysis. In this context, Jacobs et al. developed a method in which three
complementary metabolite sub-profiles were generated with different compound classes
by SPE fractionation [137]. Separation of phenolic from polar metabolites improved the
identification by reducing signal overlap in the 1H NMR spectra and increasing phenolic
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concentrations. This SPE-NMR sub-profiling method was tested on urine samples col-
lected from a crossover human nutritional intervention trial in which healthy volunteers
consumed a mixture of wine and grape polyphenol extracts or a placebo.
In another study, van der Hooft reported a procedure for the identification and
quantification of PC metabolites in urine after intake of tea using a methodology in which
MS-based SPE trapping was coupled to 1H NMR spectroscopy [138]. A urine clean-up
and preconcentration by means of SPE has also been recently employed by de Roo for the
spectral assignment of conjugated valerolactone metabolites of catechin-based polyphenols
isolated from the urine of black tea consumers [139]. In this study, an SPE-preparative
liquid chromatography (prepLC)–MS–LC–MS-NMR workflow allowed the full spectral 1H
and 13C NMR assignments of five conjugated valerolactones, applying 1D and 2D homo-
and hetero-nuclear NMR experiments.
Moazzami et al. developed a quantitative NMR analysis to ascertain the pattern of
sesamin urinary metabolites in humans. In this study, after collection by HPLC, the major
catechol metabolites were characterized by 1H-NMR, homonuclear correlation spectroscopy
(COSY), total correlation spectroscopy (TOCSY), heteronuclear multiple-bond correlation
(HMBC), HSQC, and two-dimensional nuclear Overhauser effect (NOESY) experiments,
and the excretion post-consumption of a specific dose of sesame oil was quantified from
urine extracts by 1H-NMR spectra [140].
While MS/MS and MSn fragmentation can be very helpful in metabolite characteri-
zation and identification [133], it is not useful to establish a substitution position, unless
the reference of the compounds are available [18]. Therefore, to elucidate their complete
structure, additional information from NMR spectra is required. A noteworthy application
was reported by Natsume in 2003 [141], where the elucidation of the chemical structure
of several (-)-epicatechin metabolites (methylated and glucuronidated forms) in human
and rat urine was performed by 1H NMR, 13C NMR, and HMBC (and LC-MS) analyses.
In another study, Miksits et al. located the sulfate at position 3 and identified the full
structure of the main resveratrol monosulfated metabolite by NMR experiments (1D 1H,
2D double-quantum filtered-COSY, HSQC, and HMBC) [142]. The elucidation of the truly
active structures of (+)-catechin and (-)-epicatechin in biological rat fluids was established
as (+)-catechin 5-O-β-glucuronide and (-)-epicatechin 5-O-β-glucuronide by both MS anal-
ysis and the full assignment of 1H and 13C NMR, which was achieved by 2D experiments
(COSY, HSQC, and HMBC). In this study, the conjugation position of the glucuronide was
established by HMBC spectra and was additionally corroborated by NOESY analysis [143].
4. Conclusions
The characterization of PCM in plasma and urine is a strategy to understand the
biological effects of PC present in plant-derived feeds, foods, beverages, herbal medicines,
and dietary supplements. Due to their beneficial impacts on health, considerable research
has been focused on the identification and quantification of PCM in plasma and urine
of human and rats after the consumption of dietary PC. During the last two decades,
considerable progress has been achieved in sample preparation methods (PCM extraction,
cleaning/purification, preconcentration, and derivation), allowing the analysis of PC and
PCM with differentiated physicochemical properties. However, problematic issues in
sample clean-up include a lack of commercial standards for PCM and internal standards,
metabolite degradation due to tedious multi-step sample preparation workflows, instability
of specific compounds, and low analyte concentration.
PCM analysis has benefited from recent advances in high-throughput identification
by hyphenated chromatographic techniques. The presence of PCM with highly variable
physicochemical traits (hydrophilicity, lipophilicity, and protolytic properties), their small
structural differences, and low levels of abundance remain a challenge for their identifi-
cation and quantitation by existing analytical platforms. Currently, there is lack of clear
guidelines or strategies for the identification and mainly for the targeted quantification of
PCM without standards. Reversed-phase LC is actually the best approach, but the column
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specificity (particle size or the use of core shell particles), the mobile phase, and additives
included in the mobile phases, and the performance of interface with detection systems,
especially with the MS, are all important to ensure and sustain data quality, mainly for
isomeric or isobaric compounds that are challenging and require both chromatographic
separation and mass spectrometry detection.
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